Dossier
Lupin Pharmaceuticals
Coverage of Lupin Pharmaceuticals in the Nexus archive.
- Recall alert: 2.5M bottles of eye drops recalled for foreign substance
The FDA recalled 2.5 million bottles of prednisoLONE Acetate Ophthalmic Suspension, 1%, due to potential foreign substances. The Class II recall, issued by Lupin Pharmaceuticals, addresses temporary health risks, with the initial recall on June 4 and FDA classification on June 30.
- Lupin Pharmaceuticals is recalling 2.5 million bottles of prescription steroid eye drops over contamination
Lupin Pharmaceuticals is recalling 2.5 million bottles of prescription steroid eye drops due to contamination. The FDA classified the recall as Class II, indicating potential temporary or reversible health effects from using the affected product.